Feb 07, 2018 8:30am EST Veru to Report Fiscal 2018 First-Quarter Financial Results, Host Conference Call on February 14
Feb 06, 2018 8:30am EST Veru Announces Presentation of Data Demonstrating Efficacy of VERU-111 in a Taxane Resistant Human Prostate Cancer Model at the 2018 Genitourinary Cancers Symposium
Oct 03, 2017 8:30am EDT Veru Inc. Announces Agreement with Timm Medical Technologies, LLC to Distribute and to Promote PREBOOST
Sep 26, 2017 8:37am EDT Veru Inc. Announces Initiation of Telemedicine Capability to Expand Access to Prescriptions for FC2 Female Condom
